Nephron Pharmaceuticals Corporation CEO and owner Lou Kennedy today donated fifty liters of hand sanitizer manufactured by the West Columbia company to the William Jennings Bryan Dorn VA Medical Center.
Kennedy announced earlier this week that the Food and Drug Administration had approved Nephron to produce hand sanitizer in the wake of the COVID19 pandemic.
“Our veterans and their families have sacrificed for us, and we could not be more excited to lend them a hand during this difficult time,” said Kennedy. “Americans are being challenged. We are coming together. I hope to see this spirit of community endures long after COVID19 passes.”
Nephron Pharmaceuticals Corporation develops and produces safe, affordable generic inhalation solutions and suspension products that can be used to treat symptoms of COVID19. In addition, the company operates an industry-leading 503B Outsourcing Facility division which produces pre-filled sterile syringes and IV bags for hospitals across America, in an effort to alleviate their drug shortage needs.
“Nephron employees are on the frontlines of the response to COVID19,” said Kennedy. “They are standing shoulder to shoulder with health care professionals, and we are going to keep working around the clock to deliver life-saving respiratory medications to patients.”